Definition:Mortality and expense (M&E) charge
📋 Mortality and expense (M&E) charge is a fee embedded in variable annuity and certain variable life insurance contracts that compensates the insurance company for bearing the mortality risk and expense risk associated with the product's guarantees and ongoing administration. Unlike the more visible fund management fees charged by the underlying separate account investment options, the M&E charge is assessed directly by the insurer as a percentage of the contract's account value, typically deducted daily or periodically, and is disclosed in the product's prospectus and contract documents.
⚙️ The mortality component of the charge covers the insurer's cost of providing the contract's guaranteed death benefit. In a standard variable annuity, for instance, if the contract holder dies while the account value is below a guaranteed minimum death benefit level, the insurer must make up the shortfall — a risk that becomes more significant during prolonged market downturns. The expense component compensates the insurer for the ongoing administrative costs of maintaining the policy, including policy administration, regulatory compliance, and policyholder servicing. The combined M&E charge commonly ranges from roughly 1.0 to 1.5 percent of account value annually, though the exact level varies by product and insurer. Some contracts also include a separate administrative fee or charge additional amounts for optional guaranteed living benefit riders, which sit on top of the base M&E charge.
💡 For consumers and financial advisors evaluating variable insurance products, the M&E charge is one of the most significant cost components and directly reduces the net investment return credited to the policyholder's account. Because it is assessed as a percentage of account value, the absolute dollar amount of the charge grows as the account value increases, which has drawn scrutiny from consumer advocates and regulators regarding fee transparency and suitability. The U.S. SEC and FINRA require detailed disclosure of M&E charges in variable product documentation, and the charge level is a key factor in suitability reviews. From the insurer's perspective, accurately pricing the M&E charge requires sophisticated actuarial modeling of mortality trends, policyholder behavior such as lapse rates, and equity market scenarios — making it a point of intersection between product pricing, risk management, and investment strategy.
Related concepts: